期刊文献+

1-磷酸鞘氨醇对原代骨髓间充质干细胞增殖和分化的影响

Effect of Sphingosine 1-Phosphate on Proliferation and Differentiation of Primary Bone Marrow Mesenchymal Stem Cells
下载PDF
导出
摘要 目的探讨1-磷酸鞘氨醇(S1P)在骨髓间充质干细胞增殖及诱导分化为血管内皮细胞中的作用。方法采用S1P预处理原代骨髓间充质干细胞(PR-MSCs),并评估S1P对PR-MSCs增殖和分化的影响。结果 S1P能显著促进PR-MSCs的增殖,促进PR-MSCs经血管内皮生长因子(VEGF)诱导分化为血管内皮细胞,这与经S1P处理后的PR-MSCs表达VEGF及Angiopointin-1的m RNA增多有关,同时P-ERK1/2高表达于S1P预处理后的PR-MSCs中。结论 S1P能促进PR-MSCs的增殖和分化为血管内皮细胞,并且S1P通过ERK通路影响PR-MSCs的旁分泌,这将促进PR-MSCs的临床应用以及加强对S1P作用机制的了解。 Objective To investigate the effects of sphingosine- 1 -phosphate (S1P) on the proliferation and differentiation of bone marrow mesenchymal stem cells(MSCs) into vascular endothelial cells. Methods Primary bone marrow MSCs (PR-MSCs) were pre-treated with S1P and the effects of SIP on the proliferation and differentiation of PR- MSCs was evaluated. Results The proliferation capability of PR- MSCs was significantly enhanced by SIP. Furthermore, SIP accelerated the differentiation of PR- MSCs into endothelial cells under vascular endothelial growth factor (VEGF) induction, which was related with increasing mRNA production of VEGF and Angiopointin-1 in S1P-PR-MSCs. Meanwhile, P-ERK1/2 was highly expressed in SIP treated PR-MSCs. Conclusion SIP can promote the proliferation and differentiation of PR- MSCs into vascular endothelial ceils. In addition, SIP can affect paracrine of PR- MSCs by activating ERK pathway, which can promote the clinical application of PR- MSCS and strengthen the understanding on SIP action mechanism.
出处 《中国药业》 CAS 2015年第11期28-30,共3页 China Pharmaceuticals
基金 国家自然科学基金(青年科学基金项目2012) 项目编号:81200081
关键词 1-磷酸鞘氨醇 原代骨髓间充质干细胞 增殖 分化 sphingosine - 1 - phosphate (S1P) primary bone marrow mesenchymal stem cells (PR - MSCs) proliferation differentiation
  • 相关文献

参考文献15

  • 1Tongers J, Losordo DW, Landmesser U. Stem and progenitor cell- based therapy in ischaemic heart disease: promise, uncertainties, and challenges[J]. European Heart Journal,2011,32(10) : 1 197 - 1 206.
  • 2Orlic D, Kajstura J, Chimenti S, et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival[ J ]. Proc Natl Acad Sci USA,2001,98(18) :10 344- 10 349.
  • 3Shiota M, Heike T, Haruyama M, et al. lso|ation and characterization of bone marrow- derived mesenchymal progenitor cells with myogenic and neuronal properties [ J ]. Exp Cell Res, 2007,313 (5) : 1 008 - 1 023.
  • 4Zhou L, Ma W, Yang Z, et al. VEGFI65 and angiopoietin - 1 decreased myocardium infarct size through phosphatidylinositol -3 kinase and Bcl - 2 pathways [J]. Gene Therapy,2005,12(3) : 196 - 202.
  • 5Jin J, Zhao Y, Tan X, et al. An improved transplantation strategy for mouse mesenchymal stem cells in an acute myocardial infarction model[J]. PloS One, 2011,6(6) :e21 005.
  • 6Halt NC, Oskeritzian CA, Paugh SW, et al. Sphingosine kinases, sphingo- sine- 1-phosphate, apoptosis and diseases[J]. Biochim Biophys Acta, 2006,1 758(12) :2 016 -2 026.
  • 7Jin ZQ,Goetzl E J, Karliner JS. Sphingosine kinase activation mediates is- chemic preconditioning in murine heart [ J ]. Circulation, 2004, 110 (14) : 1980-1 989.
  • 8Li QF, Wu CT, Guo Q, et al. Sphingosine - 1 -phosphate induces mel - l upregulation and protects multiple myeloma cells against apoptosis[J]. Bioehem Biophys Res Commun, 2008,371 ( 1 ) : 159 - 162.
  • 9Gnocchi M, He H, Noiseux N, et al. Evidence supporting paraerine hypoth- esis forAkt- modified mesenchymal stem cell- mediated cardiac protec- tion and functional improvement [ J ]. Faseh J, 2006,20 (6) : 661 - 669.
  • 10ttipp J, Atala A. Tissue engineering, stem cells, cloning, and partheno- genesis:new paradigms for therapy[J]. J Exp Clin Assist Reprod,2004, 1(1):3.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部